Search

Your search keyword '"Meyer, William A."' showing total 19 results

Search Constraints

Start Over You searched for: Author "Meyer, William A." Remove constraint Author: "Meyer, William A." Topic rhabdomyosarcoma Remove constraint Topic: rhabdomyosarcoma
19 results on '"Meyer, William A."'

Search Results

1. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta‐analysis.

4. Metabolic response as assessed by 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

5. Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis From Four International Cooperative Groups

6. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.

7. Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group.

8. The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

9. Local Control and Outcome in Children with Localized Vaginal Rhabdomyosarcoma: A Report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group

10. Grading of Non-Rhabdomyosarcoma Soft Tissue Sarcoma in Children and Adolescents: A Comparison of Parameters Used for the FNCLCC and POG systems

11. Primary renal sarcomas in the Intergroup Rhabdomyosarcoma Study Group (IRSG) experience, 1972-2005: A report from the Children's Oncology Group

12. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

13. Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group.

14. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

15. The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the children's oncology group.

16. Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.

17. Sclerosing Rhabdomyosarcomas in Children and Adolescents: A Clinicopathologic Review of 13 Cases From the Intergroup Rhabdomyosarcoma Study Group and Children’s Oncology Group.

18. Local Control With Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group D9602 Study

19. Protocol for the Examination of Specimens From Patients (Children and Young Adults) With Rhabdomyosarcoma.

Catalog

Books, media, physical & digital resources